Bicara Therapeutics Inc. Common Stock (BCAX) Insider Trading
Over the last 3 months, BCAX insiders made 0 open-market buys and 10 sales, a net sale of -$1.7M (SEC Form 4). Over the last 6 months, 108 institutions increased and 77 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
10
Net (3m)
-$1.7M
Insider trades by month Buys Sells
Dec
Jan
Feb
Mar
Apr
May
Context3-month price +49.3%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 10, 2026 | Simson Jakedirector | Grant | 19,475 | $20.56 |
| Jun 10, 2026 | RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner: | Grant | 19,475 | $20.56 |
| Jun 10, 2026 | Bowden Christopherdirector | Grant | 19,475 | $20.56 |
| Jun 10, 2026 | Haviland Katedirector | Grant | 19,475 | $20.56 |
| Jun 10, 2026 | Mazumdar-Shaw Kirandirector | Grant | 19,475 | $20.56 |
| Jun 10, 2026 | Robertson Scott M.director | Grant | 19,475 | $20.56 |
| Jun 10, 2026 | POWELL MICHAELdirector | Grant | 19,475 | $20.56 |
| May 26, 2026 | Hyep Ivanofficer: Chief Financial Officer | Sell | 9,200 | $20.42 |
| May 26, 2026 | Hyep Ivanofficer: Chief Financial Officer | Option | 9,200 | $3.79 |
| May 20, 2026 | Mazumdar Clairedirector, officer: Chief Executive Officer | Sell | 12,022 | $19.96 |
| May 20, 2026 | Mazumdar Clairedirector, officer: Chief Executive Officer | Sell | 2,978 | $20.35 |
| May 20, 2026 | Mazumdar Clairedirector, officer: Chief Executive Officer | Option | 15,000 | $3.79 |
| May 18, 2026 | Cohlhepp Ryandirector, officer: President and COO | Sell | 8,000 | $20.29 |
| May 18, 2026 | Cohlhepp Ryandirector, officer: President and COO | Sell | 4,500 | $20.29 |
| May 18, 2026 | Cohlhepp Ryandirector, officer: President and COO | Option | 8,000 | $3.79 |
| May 12, 2026 | Schelman Williamofficer: Chief Medical Officer | Grant | 85,000 | $22.58 |
| Apr 28, 2026 | Raben Davidofficer: Chief Medical Officer | Option | 5,500 | $3.79 |
| Apr 28, 2026 | Raben Davidofficer: Chief Medical Officer | Sell | 5,500 | $22.88 |
| Apr 22, 2026 | Hyep Ivanofficer: Chief Financial Officer | Sell | 9,200 | $23.00 |
| Apr 22, 2026 | Hyep Ivanofficer: Chief Financial Officer | Option | 9,200 | $3.79 |
| Apr 20, 2026 | Mazumdar Clairedirector, officer: Chief Executive Officer | Option | 8,226 | $4.44 |
| Apr 20, 2026 | Mazumdar Clairedirector, officer: Chief Executive Officer | Option | 7,080 | $5.45 |
| Apr 20, 2026 | Mazumdar Clairedirector, officer: Chief Executive Officer | Option | 15,000 | $3.79 |
| Apr 20, 2026 | Mazumdar Clairedirector, officer: Chief Executive Officer | Sell | 15,000 | $23.61 |
| Apr 20, 2026 | Mazumdar Clairedirector, officer: Chief Executive Officer | Option | 7,454 | $3.79 |
| Apr 17, 2026 | Cohlhepp Ryandirector, officer: President and COO | Option | 8,000 | $3.79 |
| Apr 17, 2026 | Cohlhepp Ryandirector, officer: President and COO | Sell | 4,500 | $23.01 |
| Apr 17, 2026 | Cohlhepp Ryandirector, officer: President and COO | Sell | 8,000 | $23.01 |
| Mar 26, 2026 | Raben Davidofficer: Chief Medical Officer | Option | 5,500 | $3.79 |
| Mar 26, 2026 | Raben Davidofficer: Chief Medical Officer | Sell | 5,500 | $18.95 |
Source: BCAX SEC Form 4 filings, latest Jun 10, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their BCAX positions over the last 6 months (SEC Form 13F).
Increased
108
New positions
72
Reduced
77
Sold out
40
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Increased | 7.3M | May 15, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 7.0M | Feb 17, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 6.7M | May 18, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 6.6M | May 15, 2026 |
| SIREN, L.L.C. | Increased | 5.8M | May 14, 2026 |
| VESTAL POINT CAPITAL, LP | Increased | 5.4M | May 15, 2026 |
| SIREN, L.L.C. | Unchanged | 5.2M | Feb 13, 2026 |
| DEEP TRACK CAPITAL, LP | Increased | 4.1M | May 15, 2026 |
| VESTAL POINT CAPITAL, LP | Reduced | 3.6M | Feb 17, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3.5M | May 15, 2026 |
| FMR LLC | Increased | 3.3M | Feb 17, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 3.2M | Feb 19, 2026 |
| RED TREE MANAGEMENT, LLC | Unchanged | 3.2M | Feb 11, 2026 |
| RED TREE MANAGEMENT, LLC | Unchanged | 3.2M | Apr 22, 2026 |
| TPG GP A, LLC | Unchanged | 3.0M | Feb 13, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.